MedPath

Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up

Not Applicable
Completed
Conditions
Chronic Sinusitis
Interventions
Device: Balloon Sinus Dilation
Procedure: Functional Endoscopic Sinus Surgery
Registration Number
NCT01525849
Lead Sponsor
Entellus Medical, Inc.
Brief Summary

The objective of this study is to show that long-term symptom improvement after sinus balloon dilation is not worse than symptom improvement after functional endoscopic sinus surgery (FESS) and that fewer postoperative debridements are required after balloon dilation than after FESS.

Detailed Description

This is a postmarket, multicenter, prospective, randomized clinical trial conducted at up to 15 US clinical sites comparing the efficacy of balloon sinus dilation with traditional endoscopic sinus surgery. The primary hypotheses were to demonstrate that: 1) long-term change in sinus symptoms after balloon dilation is not worse (non-inferior) than after FESS, and 2) balloon dilation is superior to FESS for a reduction in the number of postoperative debridements per patient. A minimum of 36 participants per arm is required to test the primary hypotheses. All participants will be followed through a minimum of 12 months post treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
151
Inclusion Criteria
  • 18 years or older
  • maxillary sinus disease
  • chronic sinusitis
Exclusion Criteria
  • fungal disease
  • Samter's triad
  • hemophilia
  • prior sinus surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Balloon Sinus DilationBalloon Sinus DilationXprESS Multi-Sinus Dilation Balloon, FinESS Sinus Treatment
Functional Endoscopic Sinus SurgeryFunctional Endoscopic Sinus SurgeryTraditional endoscopic sinus surgery (maxillary antrostomy and uncinectomy with optional anterior ethmoidectomy) using cutting, grasping, and microdebrider tools.
Primary Outcome Measures
NameTimeMethod
Sinus Symptom ImprovementBaseline and 1-year

Change from baseline in overall 20-item Sino-Nasal Outcome Test (SNOT-20) score. The SNOT-20 is a validated patient reported survey of 20 items related to sinonasal symptoms and severity assessed over the previous 2 weeks. Each item is scored from 0 (no problem) to 5 (problem as bad as it can be). The individual item scores are averaged to provide and overall score that ranges from 0 (best) to 5 (worst).

Debridements1-year

Number of postoperative debridements per participant

Secondary Outcome Measures
NameTimeMethod
Revision Rate1-year

Number of participants requiring repeat sinus procedures

Recovery Time6-months

Mean time (days) after procedure for participants to return to normal activities

Complication RateDuration of study (minimum of 12 months)

Number of participants experiencing 1 or more serious adverse events related to the device and/or procedure

Trial Locations

Locations (1)

Entellus Medical

🇺🇸

Plymouth, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath